Harada M - Search Results

1

Purification and immunochemical properties of tyrosine hydroxylase in human brain.

Mogi M, Kojima K, Harada M, Nagatsu T. Mogi M, et al. Among authors: harada m. Neurochem Int. 1986;8(3):423-8. doi: 10.1016/0197-0186(86)90017-3. Neurochem Int. 1986. PMID: 20493073

2

Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu T. Mogi M, et al. Among authors: harada m. J Neurochem. 1988 Apr;50(4):1053-6. doi: 10.1111/j.1471-4159.1988.tb10572.x. J Neurochem. 1988. PMID: 2894407

3

Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain.

Mogi M, Harada M, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T. Mogi M, et al. Among authors: harada m. J Neural Transm. 1988;72(1):77-82. doi: 10.1007/BF01244634. J Neural Transm. 1988. PMID: 2897999

4

Sandwich enzyme immunoassay of dopamine-?-hydroxylase in cerebrospinal fluid from control and parkinsonian patients.

Mogi M, Harada M, Kojima K, Inagaki H, Kondo T, Narabayashi H, Arai T, Teradaira R, Fujita K, Kiuchi K, Nagatsu T. Mogi M, et al. Among authors: harada m. Neurochem Int. 1988;12(2):187-91. doi: 10.1016/0197-0186(88)90126-x. Neurochem Int. 1988. PMID: 20501220

5

Beta 2-microglobulin decrease in cerebrospinal fluid from parkinsonian patients.

Mogi M, Harada M, Kojima K, Adachi T, Narabayashi H, Fujita K, Naoi M, Nagatsu T. Mogi M, et al. Among authors: harada m. Neurosci Lett. 1989 Sep 25;104(1-2):241-6. doi: 10.1016/0304-3940(89)90361-3. Neurosci Lett. 1989. PMID: 2682394

6

Selective removal of beta 2-microglobulin from human plasma by high-performance immunoaffinity chromatography.

Mogi M, Harada M, Adachi T, Kojima K, Nagatsu T. Mogi M, et al. Among authors: harada m. J Chromatogr. 1989 Nov 10;496(1):194-200. doi: 10.1016/s0378-4347(00)82566-9. J Chromatogr. 1989. PMID: 2687311 No abstract available.

7

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T. Mogi M, et al. Among authors: harada m. Neurosci Lett. 1987 Sep 23;80(2):213-8. doi: 10.1016/0304-3940(87)90656-2. Neurosci Lett. 1987. PMID: 2891089

8

Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).

Ozaki N, Nakahara D, Mogi M, Harada M, Kiuchi K, Kaneda N, Miura Y, Kasahara Y, Nagatsu T. Ozaki N, et al. Among authors: harada m. Neurosci Lett. 1988 Feb 29;85(2):228-32. doi: 10.1016/0304-3940(88)90356-4. Neurosci Lett. 1988. PMID: 2897647

9

Purification and properties of mitochondrial monoamine oxidase in beef brain.

Harada M, Mizutani K, Nagatsu T. Harada M, et al. J Neurochem. 1971 Apr;18(4):559-69. doi: 10.1111/j.1471-4159.1971.tb11986.x. J Neurochem. 1971. PMID: 5581571 No abstract available.

10

Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease.

Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Mogi M, et al. Among authors: harada m. Neurosci Lett. 1995 Jun 30;193(2):129-32. doi: 10.1016/0304-3940(95)11686-q. Neurosci Lett. 1995. PMID: 7478158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,925 results

Search Page

Filters